European stock indices edge lower, led by U.K. shares amid disappointing earnings reports and accelerating consumer price growth. Fund manager pressure mounts on the board of Britain’s No. 2 drugs maker AstraZeneca to entertain a thrice-sweetened $117 billion bid from pharmaceuticals giant Pfizer following a statement from Schroders, while FTSE 100 stalwarts Vodafone Group, the telecom, and variety-store retailer Marks & Spencer both decline after reporting full-year earnings figures. Vodafone says investment will rein in profit in the current year and Marks & Spencer fails to wow shareholders with upbeat commentary on the margin outlook.

More from Video

Video: This One Mathematical Concept Can Make You a Millionaire

Video: This One Mathematical Concept Can Make You a Millionaire

AAP Exclusive: Nvidia is Tied to Crypto and That's Bad

AAP Exclusive: Nvidia is Tied to Crypto and That's Bad

Video: Abercrombie & Fitch Shares Surged 57% So Far This Year

Video: Abercrombie & Fitch Shares Surged 57% So Far This Year

Video: Why It's Key to Invest in Stocks Even If You Have Student Loan Debt

Video: Why It's Key to Invest in Stocks Even If You Have Student Loan Debt

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs